MIR6814

Across TCGA pan-cancer cohorts, MIR6814 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR6814’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR6814 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6814 is over-expressed in tumor, although a few such as KICH and BRCA show the opposite, repressed pattern.

KIRC, LUSC, and KICH are the cancer types where MIR6814 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6814 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.361	<.001	3	view →
LUSC	All	All	+0.513	.001	2	view →
KICH	All	All	−0.271	.018	2	view →
BRCA	Female	All	−0.167	.025	2	view →
COAD	All	All	+0.338	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR6814–KIRC

Open the KIRC breakdown →